JAGUAHR THERAPEUTICS PTE. LTD.
Country of registration | Singapore |
Registration number | 201926902D |
Local SIC | |
Incorporation date | 16 Aug 2019 |
Company age | 6 years 9 months |
Official entity type | Exempt Private Limited Company |
No. of officers | 19 |
Contact
5 SHENTON WAY, #10-01, UIC BUILDING, Singapore 068808
This is the legal entity page of JAGUAHR THERAPEUTICS PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
- JAGUAHR THERAPEUTICSView MoreSingaporeJAGUAHR Therapeutics is dedicated to advancing the field of immuno-oncology by leveraging the Aryl Hydrocarbon Receptor (AhR) pathway to develop novel therapeutic solutions for cancer treatment. Our cutting-edge technology aims to harness the body's natural defense mechanisms to combat cancer with increased efficacy and minimal side effects.
Auditor | DELOITTE & TOUCHE LLP |
Revenue | < 1m |
Share Capital - Ordinary shares | USD 5,000,771 |
Frequently Asked Questions (FAQ)
- What is the address of JAGUAHR THERAPEUTICS PTE. LTD.?
- Where is JAGUAHR THERAPEUTICS PTE. LTD.'s headquarter?
- What is JAGUAHR THERAPEUTICS PTE. LTD.'s contact number?
- What JAGUAHR THERAPEUTICS PTE. LTD.'s spending power?
- Does JAGUAHR THERAPEUTICS PTE. LTD. have a presence in the domain it operates in?

